Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLIA fluconazole pharmacokinetics in obese and non-obese adults
NL-OMON45817Phase 4Active, not recruiting
- Sponsor
- Klinische Farmacie
- Start
- Nov 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of fluconazole in candidiasis, invasive candidiasis and mycoses (2 cohorts), sponsored by Klinische Farmacie. Primary endpoints: Population pharmacokinetic model of fluconazole, Model validation and 1 more. Started Nov 2019; status: active, not recruiting.
02
Drugs
fluconazole
03
Conditions
candidiasisinvasive candidiasismycoses
Beyond the preview
Go deeper on NL-OMON45817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45817.